Über das Unternehmen
- Firmenname (rechtlich): Croda pharma
- Registrierungsland: United Kingdom
- Adresse: Cowick, Snaith, East Cowick, Goole
- Anzahl der Mitarbeiter: 1000 - 4999
Beschreibung:
Croda Pharma is a leading partner for developing excipients and supplying high-purity materials for pharmaceutical formulations, offering high-purity excipients that enhance delivery, efficacy and stability of active ingredients, along with high-performing vaccine adjuvants and in-house formulation expertise to navigate drug and vaccine formulation challenges. The company focuses on enabling biologics drug delivery through its adjuvant systems and small molecule, protein and nucleic acid delivery platforms, offering solutions for both human and animal health markets backed by substantial investment in GMP and multi-site EXCiPACT accreditation.
Geschäftsaktivitäten
Hilfsstoffe & Zusatzstoffe
HerstellerLohnhersteller (CMO)Hilfsstofflieferant
Naturextrakte & Pflanzliche Rohstoffe
HerstellerLohnhersteller (CMO)Hilfsstofflieferant
Pharmazeutische Chemikalien
HerstellerLohnhersteller (CMO)Hilfsstofflieferant
Absatzmärkte
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
Hauptprodukte/-dienstleistungen
- Vertrags- & Outsourcing-Dienstleistungen: Adjuvant Systems for Vaccines
- Hilfsstoffe & Zusatzstoffe: Excipient: Super Refined™ PEG 400, Excipient: Super Refined™ Polysorbate 80, Excipient: Super Refined™ Polysorbate 20, Excipient: Super Refined™ DEGEE, Excipient: Super Refined™ P35 Caster Oil, Tween™ 80 HP, Super Refined™ PGML, Cholesterol, Crodafos™ CES pharma, Super Refined™ GMCC, Super Refined™ L18 POG, Super Refined™ O18 POG, Excipients for Consumer Health, Super Refined™ Benzyl Alcohol, Super Refined™ DMI, Super Refined™ GTCC, Super Refined™ PEG 300
- Pharmazeutische Chemikalien: Nucleic Acid Delivery for Vaccines and Next-Gen Therapeutics
- Biopharmazeutische Produkte: Cationic Adjuvant Formulation CAF®
- Biopharmazeutische Dienstleistungen: Bioprocessing solutions and excipients for protein therapeutic formulations
- ATC-Klassifikation (Anatomisch-Therapeutisch-Chemisch): ALC-0315
- Original-Wirkstoffe: ENT-DSPC, Vaccine Adjuvant: Alhydrogel™, Vaccine Adjuvant: Quil-A™
Unsere Produkte & Dienstleistungen
Sell · ATC (Anatomical Therapeutic Chemical) Classification
Certifications
GMP
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Bewertungen
(0)
(0)
(0)
(0)
(0)
Kommentare
Filter:
Sortieren nach:
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen